This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 26 November - 2 December 2023 and includes updates on human infection with influenza A(H1N2)v, influenza A(H5N1), an overview of respiratory virus epidemiology in the EU/EEA, respiratory infections due to Mycoplasma pneumoniae in the EU/EEA, HIV/AIDS surveillance 2023 (2022 data), West Nile virus, SARS-CoV-2 variant classification, and poliomyelitis.
Mumps is a viral infection first described by Hippocrates that in its classical form causes acute parotitis and, less frequently, orchitis, meningitis and pneumonia.
Poliovirus is highly contagious and infected individuals shed virus in the faeces and from oral secretions, thus the mode of transmission is person-to-person, both via the faecal-oral and the oral-oral routes.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19 - 25 November 2023 and includes updates on updates SARS-CoV-2 variant classifications, the increase of pediatric respiratory infections in China, Avian influenza in fur farms, West Nile virus, cholera, and an overview of respiratory virus epidemiology.
In 2023 and until the beginning of November, over 4.5 million cases and over 4 000 dengue-related deaths have been reported from 80 countries/territories globally.
In 2023 and until the beginning of November, over 4.5 million cases and over 4 000 dengue-related deaths have been reported from 80 countries/territories globally.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5 - 11 November 2023 and includes updates on SARS-CoV-2 variants, an overview of respiratory virus epidemiology in the EU/EEA, West Nile Virus, measles, diphtheria, Middle East respiratory virus syndrome, chikungunya, and dengue.
This document is an update of the joint guidance that was published in 2011 by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).